Ireland· IE-PA-PA0549/020/001
Magnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusion
A magnesium sulfate product containing magnesium sulphate heptahydrate, registered in Ireland by Ethypharm. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Magnesium sulfate is registered in 11 of 19 countries.
Countries holding a registration under ATC B05XA05 (magnesium sulfate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Magnesium sulfate · ATC B05XA05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Magnesium sulphate heptahydrate
- Manufacturer
- Ethypharm
- Country
- Ireland (IE)
- ATC code
- B05XA05
- ATC class
- Magnesium sulfate
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0549/020/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for magnesium sulfate.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium sulfate · interactions on record
115 records
- 16 severe
- 98 moderate
- 1 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- KanamycinA07AA08severe
- NeomycinB05CA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magnesium sulfate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a327c13-7182-4d56-a465-90c893e3e4d8 GET /v1/drugs/2a327c13-7182-4d56-a465-90c893e3e4d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"routes": [
"Intramuscular use",
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05XA",
"B05XA05"
],
"strength": null,
"pa_number": "PA0549/020/001",
"substances": [
"Magnesium sulphate heptahydrate"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "26/05/2006",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about magnesium sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.